{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:53:48Z","timestamp":1780588428591,"version":"3.54.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006520","name":"edwards lifesciences","doi-asserted-by":"publisher","award":["Improving the Prevention and Detection of Heart Valve Disease Across the Lifespan, 2021"],"award-info":[{"award-number":["Improving the Prevention and Detection of Heart Valve Disease Across the Lifespan, 2021"]}],"id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"funda\u00e7\u00e3o de amparo \u00e0 pesquisa do estado de minas gerais","doi-asserted-by":"publisher","award":["APQ-000627-20"],"award-info":[{"award-number":["APQ-000627-20"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"conselho nacional de desenvolvimento cient\u00edfico e tecnol\u00f3gico","doi-asserted-by":"publisher","award":["312382\/2019-7"],"award-info":[{"award-number":["312382\/2019-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11886-021-01592-2","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T19:44:45Z","timestamp":1633117485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The Global Impact of Rheumatic Heart Disease"],"prefix":"10.1007","volume":"23","author":[{"given":"Joselyn","family":"Rwebembera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Z.","family":"Beaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"de Loizaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo T. L.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakagaayi","family":"Doreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Ssinabulya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmy","family":"Okello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara L.","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno F.","family":"Galdino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmo P.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5586-774X","authenticated-orcid":false,"given":"Bruno R.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"issue":"4","key":"1592_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.1924.02650300047013","volume":"82","author":"GFDGH Dick","year":"1924","unstructured":"Dick GFDGH. The etiology of scarlet fever. J Am Med Assoc. 1924;82(4):301\u20132.","journal-title":"J Am Med Assoc"},{"key":"1592_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2261-5-11","volume":"5","author":"KA Robertson","year":"2005","unstructured":"Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord. 2005;5:11.","journal-title":"BMC Cardiovasc Disord"},{"key":"1592_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1056\/NEJM197308162890701","volume":"289","author":"L Gordis","year":"1973","unstructured":"Gordis L. Effectiveness of comprehensive-care programs in preventing rheumatic fever. N Engl J Med. 1973;289:331\u20135.","journal-title":"N Engl J Med"},{"key":"1592_CR4","doi-asserted-by":"crossref","unstructured":"Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev.\u00a02002:CD002227.","DOI":"10.1002\/14651858.CD002227"},{"key":"1592_CR5","first-page":"285","volume":"59","author":"T Strasser","year":"1981","unstructured":"Strasser T, Dondog N, El Kholy A, et al. The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull World Health Organ. 1981;59:285\u201394.","journal-title":"Bull World Health Organ"},{"key":"1592_CR6","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"\u2022 Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982\u20133021.\u00a0This study reports the most up-to-date information on the global burden of cardiovascular disease worldwide, depicting current trends for Rheumatic Heart Disease.","journal-title":"J Am Coll Cardiol"},{"key":"1592_CR7","unstructured":"Organization WH. Rheumatic fever and rheumatic heart disease. Executive Board, 141st Session: resolutions and decisions, annexes, summary records. Geneva, Switzerland, 2018."},{"key":"1592_CR8","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/archinternmed.2012.3310","volume":"172","author":"A Damasceno","year":"2012","unstructured":"Damasceno A, Mayosi BM, Sani M, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries: results of the sub-Saharan Africa survey of heart failure. Arch Intern Med. 2012;172:1386\u201394.","journal-title":"Arch Intern Med"},{"key":"1592_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJMoa1603693","volume":"377","author":"DA Watkins","year":"2017","unstructured":"Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart disease, 1990\u20132015. N Engl J Med. 2017;377:713\u201322.","journal-title":"N Engl J Med"},{"key":"1592_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ihj.2015.07.039","volume":"68","author":"AK Islam","year":"2016","unstructured":"Islam AK, Majumder AA. Rheumatic fever and rheumatic heart disease in Bangladesh: a review. Indian Heart J. 2016;68:88\u201398.","journal-title":"Indian Heart J"},{"key":"1592_CR11","doi-asserted-by":"crossref","unstructured":"Baker MG, Gurney J, Oliver J, et al. Risk factors for acute rheumatic fever: literature review and protocol for a case-control study in New Zealand. Int J Environ Res Public Health.\u00a02019;16.","DOI":"10.3390\/ijerph16224515"},{"key":"1592_CR12","doi-asserted-by":"crossref","unstructured":"Katzenellenbogen JM, Bond-Smith D, Seth RJ, et al. Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: the case for policy change. J Am Heart Assoc.\u00a02020;9:e016851.","DOI":"10.1161\/JAHA.120.016851"},{"issue":"Suppl 10","key":"1592_CR13","first-page":"S3","volume":"213","author":"R Wyber","year":"2020","unstructured":"Wyber R, Noonan K, Halkon C, et al. Ending rheumatic heart disease in Australia: the evidence for a new approach. Med J Aust. 2020;213(Suppl 10):S3\u201331.","journal-title":"Med J Aust"},{"key":"1592_CR14","first-page":"555","volume":"64","author":"A Beaudoin","year":"2015","unstructured":"Beaudoin A, Edison L, Introcaso CE, et al. Acute rheumatic fever and rheumatic heart disease among children\u2013American Samoa, 2011\u20132012. MMWR Morb Mortal Wkly Rep. 2015;64:555\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1592_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1440-1754.2010.01997.x","volume":"47","author":"BM Reeves","year":"2011","unstructured":"Reeves BM, Kado J, Brook M. High prevalence of rheumatic heart disease in Fiji detected by echocardiography screening. J Paediatr Child Health. 2011;47:473\u20138.","journal-title":"J Paediatr Child Health"},{"key":"1592_CR16","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1161\/CIRCULATIONAHA.105.539775","volume":"112","author":"MR Essop","year":"2005","unstructured":"Essop MR, Nkomo VT. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation. 2005;112:3584\u201391.","journal-title":"Circulation"},{"key":"1592_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/heartjnl-2018-313171","volume":"105","author":"A Scheel","year":"2019","unstructured":"Scheel A, Ssinabulya I, Aliku T, et al. Community study to uncover the full spectrum of rheumatic heart disease in Uganda. Heart. 2019;105:60\u20136.","journal-title":"Heart"},{"key":"1592_CR18","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/archinternmed.2012.3310","volume":"172","author":"A Damasceno","year":"2012","unstructured":"Damasceno A, Mayosi BM, Sani M, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med. 2012;172:1386\u201394.","journal-title":"Arch Intern Med"},{"key":"1592_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-53540-4","volume":"9","author":"JJ Noubiap","year":"2019","unstructured":"Noubiap JJ, Agbor VN, Bigna JJ, Kaze AD, Nyaga UF, Mayosi BM. Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies. Sci Rep. 2019;9:1\u201314.","journal-title":"Sci Rep"},{"key":"1592_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamacardio.2020.7050","volume":"6","author":"P Karki","year":"2021","unstructured":"\u2022 Karki P, Uranw S, Bastola S, et al. Effectiveness of systematic echocardiographic screening for rheumatic heart disease in Nepalese schoolchildren: a cluster randomized clinical trial. JAMA Cardiology. 2021;6:420\u20136.\u00a0This study is the first large-scale trial testing the strategy of systematic echcardiographic screening on outcomes of individuals with Rheumatic Heart Disease, providing additional evidence to screening in clinical practice,  noticeably in endemic settings.","journal-title":"JAMA cardiology"},{"key":"1592_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ahj.2019.06.001","volume":"215","author":"A Beaton","year":"2019","unstructured":"\u2022\u2022 Beaton A, Okello E, Engelman D, et al. Determining the impact of benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (goal trial): study protocol for a randomized controlled trial. Am Heart J. 2019;215:95\u2013105.\u00a0This is the protocol of the first randomized trial evaluating the effects of penicillin on clinical and echocardiographic outcomes of children with subclinical Rheumatic Heart Disease and high-risk features.","journal-title":"Am Heart J"},{"key":"1592_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.acvd.2015.12.004","volume":"109","author":"S Kingue","year":"2016","unstructured":"Kingue S, Ba SA, Balde D, et al. The VALVAFRIC study: a registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis. 2016;109:321\u20139.","journal-title":"Arch Cardiovasc Dis"},{"key":"1592_CR23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/eurheartj\/ehu449","volume":"36","author":"L Z\u00fchlke","year":"2015","unstructured":"Z\u00fchlke L, Engel ME, Karthikeyan G, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the global rheumatic heart disease registry (the REMEDY study). Eur Heart J. 2015;36:1115\u201322.","journal-title":"Eur Heart J"},{"key":"1592_CR24","first-page":"82","volume":"24","author":"E Okello","year":"2013","unstructured":"Okello E, Wanzhu Z, Musoke C, et al. Cardiovascular complications in newly diagnosed rheumatic heart disease patients at Mulago Hospital, Uganda.\u00a0Cardiovasc J Afr. 2013;24:82.","journal-title":"Uganda Cardiovascular journal of Africa"},{"key":"1592_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5830\/CVJA-2012-076","volume":"24","author":"W Zhang","year":"2013","unstructured":"Zhang W, Mondo C, Okello E, et al. Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study: cardiovascular topics. Cardiovasc J Afr. 2013;24:28\u201333.","journal-title":"Cardiovasc J Afr"},{"key":"1592_CR26","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jacc.2018.06.063","volume":"72","author":"DA Watkins","year":"2018","unstructured":"Watkins DA, Beaton AZ, Carapetis JR, et al. Rheumatic heart disease worldwide: JACC scientific expert panel. J Am Coll Cardiol. 2018;72:1397\u2013416.","journal-title":"J Am Coll Cardiol"},{"key":"1592_CR27","doi-asserted-by":"crossref","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke.\u00a01991;22:983\u201388.","DOI":"10.1161\/01.STR.22.8.983"},{"key":"1592_CR28","doi-asserted-by":"publisher","first-page":"e576S","DOI":"10.1378\/chest.11-2305","volume":"141","author":"RP Whitlock","year":"2012","unstructured":"Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH. Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e576S-e600S.","journal-title":"Chest"},{"key":"1592_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74:104\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"1592_CR30","doi-asserted-by":"crossref","unstructured":"Semakula JR, Kisa G, Mouton JP, et al. Anticoagulation in sub-Saharan Africa: are direct oral anticoagulants the answer? A review of lessons learnt from warfarin. Br J Clin Pharmacol.\u00a02021.","DOI":"10.22541\/au.160495482.25538848\/v1"},{"key":"1592_CR31","doi-asserted-by":"publisher","first-page":"205031211666312","DOI":"10.1177\/2050312116663123","volume":"4","author":"G Ene","year":"2016","unstructured":"Ene G, Garcia Raso A, Gonzalez-Dominguez Weber A, Hidalgo-Vega A, Llamas P. Cost of vitamin K antagonist anticoagulant treatment in patients with metallic prosthetic valve in mitral position. SAGE Open Med. 2016;4:2050312116663123.","journal-title":"SAGE Open Med"},{"key":"1592_CR32","unstructured":"Guimaraes HP, Lopes RD, de Barros ESPGM, et al. Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve. N Engl J Med.\u00a02020;383:2117\u201326."},{"key":"1592_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ahj.2020.03.018","volume":"225","author":"G Karthikeyan","year":"2020","unstructured":"Karthikeyan G, Connolly SJ, Ntsekhe M, et al. The INVICTUS rheumatic heart disease research program: rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation. Am Heart J. 2020;225:69\u201377.","journal-title":"Am Heart J"},{"key":"1592_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-016-0451-8","volume":"17","author":"E Okello","year":"2017","unstructured":"Okello E, Longenecker CT, Beaton A, Kamya MR, Lwabi P. Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation. BMC Cardiovasc Disord. 2017;17:1\u201310.","journal-title":"BMC Cardiovasc Disord"},{"key":"1592_CR35","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.21037\/cdt.2016.10.06","volume":"6","author":"KH Yangni-Angate","year":"2016","unstructured":"Yangni-Angate KH, Meneas C, Diby F, Diomande M, Adoubi A, Tanauh Y. Cardiac surgery in Africa: a thirty-five year experience on open heart surgery in Cote d\u2019Ivoire. Cardiovascular Diagnosis and Therapy. 2016;6:S44.","journal-title":"Cardiovascular diagnosis and therapy"},{"key":"1592_CR36","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jcin.2018.05.039","volume":"11","author":"RA Meneguz-Moreno","year":"2018","unstructured":"Meneguz-Moreno RA, Costa JR Jr, Gomes NL, et al. Very long term follow-up after percutaneous balloon mitral valvuloplasty. JACC Cardiovasc Interv. 2018;11:1945\u201352.","journal-title":"JACC Cardiovasc Interv"},{"key":"1592_CR37","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/heartjnl-2015-308091","volume":"102","author":"MC Nunes","year":"2016","unstructured":"Nunes MC, Nascimento BR, Lodi-Junqueira L, Tan TC, Athayde GR, Hung J. Update on percutaneous mitral commissurotomy. Heart. 2016;102:500\u20137.","journal-title":"Heart"},{"key":"1592_CR38","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1161\/CIRCULATIONAHA.111.055905","volume":"125","author":"C Bouleti","year":"2012","unstructured":"Bouleti C, Iung B, Laouenan C, et al. Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients. Circulation. 2012;125:2119\u201327.","journal-title":"Circulation"},{"key":"1592_CR39","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/CIRCULATIONAHA.113.001252","volume":"129","author":"MC Nunes","year":"2014","unstructured":"Nunes MC, Tan TC, Elmariah S, et al. The echo score revisited: impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty. Circulation. 2014;129:886\u201395.","journal-title":"Circulation"},{"key":"1592_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5830\/CVJA-2015-090","volume":"27","author":"D Watkins","year":"2016","unstructured":"Watkins D, Zuhlke L, Engel M, et al. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communique. Cardiovasc J Afr. 2016;27:184\u20137.","journal-title":"Cardiovasc J Afr"},{"key":"1592_CR41","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.4314\/ahs.v15i4.17","volume":"15","author":"W Zhang","year":"2015","unstructured":"Zhang W, Okello E, Nyakoojo W, Lwabi P, Mondo CK. Proportion of patients in the Uganda rheumatic heart disease registry with advanced disease requiring urgent surgical interventions. Afr Health Sci. 2015;15:1182\u20138.","journal-title":"Afr Health Sci"},{"key":"1592_CR42","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0140-6736(15)60235-5","volume":"385","author":"M Mirabel","year":"2015","unstructured":"Mirabel M, Grimaldi A, Freers J, Jouven X, Marijon E. Access to cardiac surgery in sub-Saharan Africa. The Lancet. 2015;385:606.","journal-title":"The Lancet"},{"key":"1592_CR43","first-page":"147","volume-title":"Acute Rheumatic Fever and Rheumatic Heart Disease","author":"MJ Antunes","year":"2020","unstructured":"Antunes MJ, Finucane K, Kumar AS, Coutinho GF. Surgical management of rheumatic valvular heart disease. In: Carapetis J, Z\u00fchlke L, Wilson N, editors. Acute Rheumatic Fever and Rheumatic Heart Disease. Ireland: Elsevier; 2020. p 147\u201370."},{"key":"1592_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1749-8090-6-57","volume":"6","author":"F Edwin","year":"2011","unstructured":"Edwin F, Aniteye E, Tettey MM, Tamatey M, Frimpong-Boateng K. Outcome of left heart mechanical valve replacement in West African children-A 15-year retrospective study. J Cardiothorac Surg. 2011;6:1\u20138.","journal-title":"J Cardiothorac Surg"},{"key":"1592_CR45","doi-asserted-by":"crossref","unstructured":"Milne O, Barthwal R, Agahari I, Ilton M, Kangaharan N. Management and outcomes of prosthetic valve thrombosis. An Australian case series from the northern territory. Heart Lung Circ.\u00a02020;29:469\u201374.","DOI":"10.1016\/j.hlc.2019.07.005"},{"key":"1592_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/17434440.2020.1733972","volume":"17","author":"S G\u00fcnd\u00fcz","year":"2020","unstructured":"G\u00fcnd\u00fcz S, Kal\u00e7\u0131k M, G\u00fcrsoy MO, G\u00fcner A, \u00d6zkan M. Diagnosis, treatment & management of prosthetic valve thrombosis: the key considerations. Expert Rev Med Devices. 2020;17:209\u201321.","journal-title":"Expert Rev Med Devices"},{"key":"1592_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","volume":"70","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70:252\u201389.","journal-title":"J Am Coll Cardiol"},{"key":"1592_CR48","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","volume":"369","author":"JW Eikelboom","year":"2013","unstructured":"Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369:1206\u201314.","journal-title":"N Engl J Med"},{"key":"1592_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/CLEP.S12977","volume":"3","author":"MD Seckeler","year":"2011","unstructured":"Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3:67.","journal-title":"Clin Epidemiol"},{"key":"1592_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0146-0005(00)80047-6","volume":"24","author":"KL Thornburg","year":"2000","unstructured":"Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol. 2000;24:11\u20134.","journal-title":"Semin Perinatol"},{"key":"1592_CR51","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/CIRCULATIONAHA.117.032561","volume":"137","author":"IM van Hagen","year":"2018","unstructured":"van Hagen IM, Thorne SA, Taha N, et al. Pregnancy outcomes in women with rheumatic mitral valve disease: results from the registry of pregnancy and cardiac disease. Circulation. 2018;137:806\u201316.","journal-title":"Circulation"},{"key":"1592_CR52","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/heartjnl-2018-313810","volume":"105","author":"A Beaton","year":"2019","unstructured":"Beaton A, Okello E, Scheel A, et al. Impact of heart disease on maternal, fetal and neonatal outcomes in a low-resource setting. Heart. 2019;105:755\u201360.","journal-title":"Heart"},{"key":"1592_CR53","doi-asserted-by":"crossref","unstructured":"Nascimento BR, Sable C, Nunes MCP, et al. Echocardiographic screening of pregnant women by non-physicians with remote interpretation in primary care. Family Practice.\u00a02020.","DOI":"10.1093\/fampra\/cmaa115"},{"key":"1592_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijcard.2014.10.105","volume":"178","author":"F Arioli","year":"2015","unstructured":"Arioli F, Ammirati E. Mitral prosthetic valve thrombosis and cardiogenic shock in a limited resource setting in sub-Saharan Africa: a tailored treatment approach. Int J Cardiol. 2015;178:65\u20136.","journal-title":"Int J Cardiol"},{"key":"1592_CR55","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/bdra.23435","volume":"106","author":"S Basu","year":"2016","unstructured":"Basu S, Aggarwal P, Kakani N, Kumar A. Low-dose maternal warfarin intake resulting in fetal warfarin syndrome: in search for a safe anticoagulant regimen during pregnancy. Birth Defects Res A. 2016;106:142\u20137.","journal-title":"Birth Defects Res A"},{"key":"1592_CR56","doi-asserted-by":"publisher","first-page":"S351","DOI":"10.1016\/j.ajog.2015.10.708","volume":"214","author":"RD D'Souza","year":"2016","unstructured":"D\u2019Souza RD, Ostro J, Malinowski A, et al. 662: Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Am J Obstet Gynecol. 2016;214:S351.","journal-title":"Am J Obstet Gynecol"},{"key":"1592_CR57","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/eurheartj\/ehx032","volume":"38","author":"R D\u2019Souza","year":"2017","unstructured":"D\u2019Souza R, Ostro J, Shah PS, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017;38:1509\u201316.","journal-title":"Eur Heart J"},{"key":"1592_CR58","doi-asserted-by":"crossref","unstructured":"Xu Z, Fan J, Luo X, et al. Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and meta-analysis. Can J Cardiol.\u00a02016;32:1248. e1\u20131248. e9.","DOI":"10.1016\/j.cjca.2015.11.005"},{"key":"1592_CR59","doi-asserted-by":"crossref","unstructured":"French KA, Poppas A. Rheumatic heart disease in pregnancy: global challenges and clear opportunities. Am Heart Assoc.\u00a02018.","DOI":"10.1161\/CIRCULATIONAHA.118.033465"},{"key":"1592_CR60","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1186\/s12884-020-03189-z","volume":"20","author":"S Voleti","year":"2020","unstructured":"Voleti S, Okello E, Murali M, et al. The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study. BMC Pregnancy Childbirth. 2020;20:611.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1592_CR61","doi-asserted-by":"crossref","unstructured":"Chang AY, Nabbaale J, Nalubwama H, et al. Motivations of women in Uganda living with rheumatic heart disease: a mixed methods study of experiences in stigma, childbearing, anticoagulation, and contraception. PloS One.\u00a02018;13:e0194030.","DOI":"10.1371\/journal.pone.0194030"},{"key":"1592_CR62","unstructured":"PREVENTION of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Pediatrics.\u00a01955;15:642\u20136."},{"key":"1592_CR63","unstructured":"WHO. Rheumatic fever and rheumatic heart disease. In: Organization WH, editor. Geneva, 2001."},{"key":"1592_CR64","unstructured":"WHF. Diagnosis and mangement of acute rheumatic fever and rheumatic heart disease. In: Federation WH, editor. Geneva, Switzerland, 2008."},{"key":"1592_CR65","unstructured":"Australia R. Australian guideline for prevention, diagnosis and mangement of acute rheumatic fever and rheumatic heart disease. In: Zealand NHFoAaCSoAaN, editor. Darwin, Australia, 2020."},{"key":"1592_CR66","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.gheart.2013.08.011","volume":"8","author":"R Wyber","year":"2013","unstructured":"Wyber R, Taubert K, Marko S, Kaplan EL. Benzathine Penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement. Glob Heart. 2013;8:227\u201334.","journal-title":"Glob Heart"},{"key":"1592_CR67","doi-asserted-by":"crossref","unstructured":"Taubert K, Marko S. Access to essential medicines: illuminating disparities in the global supply of benzathine penicillin G in the context of rheumatic fever\/rheumatic heart disease. J Am Coll Cardiol.\u00a02013;61:e-2004.","DOI":"10.1016\/S0735-1097(13)62004-5"},{"key":"1592_CR68","doi-asserted-by":"crossref","unstructured":"de Dassel JL, de Klerk N, Carapetis JR, Ralph AP. How many doses make a difference? An Analysis of secondary prevention of rheumatic fever and rheumatic heart disease. J Am Heart Assoc.\u00a02018;7:e010223.","DOI":"10.1161\/JAHA.118.010223"},{"key":"1592_CR69","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1573403X13666170116120828","volume":"13","author":"PM Kevat","year":"2017","unstructured":"Kevat PM, Reeves BM, Ruben AR, Gunnarsson R. Adherence to secondary prophylaxis for acute rheumatic fever and rheumatic heart disease: a systematic review. Curr Cardiol Rev. 2017;13:155\u201366.","journal-title":"Curr Cardiol Rev"},{"key":"1592_CR70","doi-asserted-by":"crossref","unstructured":"Read C, Mitchell AG, de Dassel JL, et al. Qualitative evaluation of a complex intervention to improve rheumatic heart disease secondary prophylaxis. J Am Heart Assoc.\u00a02018;7.","DOI":"10.1161\/JAHA.118.009376"},{"key":"1592_CR71","doi-asserted-by":"crossref","unstructured":"Ralph AP, de Dassel JL, Kirby A, et al. Improving delivery of secondary prophylaxis for rheumatic heart disease in a high-burden setting: outcome of a stepped-wedge, community, randomized trial. J Am Heart Assoc.\u00a02018;7.","DOI":"10.1161\/JAHA.118.009308"},{"key":"1592_CR72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5339\/gcsp.2015.40","volume":"2015","author":"A Balbaa","year":"2015","unstructured":"Balbaa A, ElGuindy A, Pericak D, Yacoub MH, Schwalm JD. An evaluation of secondary prophylaxis for rheumatic heart disease in rural Egypt. Glob Cardiol Sci Pract. 2015;2015:40.","journal-title":"Glob Cardiol Sci Pract"},{"key":"1592_CR73","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1179\/2047773214Y.0000000146","volume":"108","author":"SB Thompson","year":"2014","unstructured":"Thompson SB, Brown CH, Edwards AM, Lindo JL. Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever. Jamaica Pathog Glob Health. 2014;108:229\u201334.","journal-title":"Jamaica Pathog Glob Health"},{"key":"1592_CR74","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/trstmh\/trx035","volume":"111","author":"D Engelman","year":"2017","unstructured":"Engelman D, Ah Kee M, Mataika RL, et al. Secondary prevention for screening detected rheumatic heart disease: opportunities to improve adherence. Trans R Soc Trop Med Hyg. 2017;111:154\u201362.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1592_CR75","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1440-1584.2003.00531.x","volume":"11","author":"CM Mincham","year":"2003","unstructured":"Mincham CM, Toussaint S, Mak DB, Plant AJ. Patient views on the management of rheumatic fever and rheumatic heart disease in the Kimberley: a qualitative study. Aust J Rural Health. 2003;11:260\u20135.","journal-title":"Aust J Rural Health"},{"key":"1592_CR76","doi-asserted-by":"crossref","unstructured":"Huck DM, Nalubwama H, Longenecker CT, Frank SH, Okello E, Webel AR. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda. Glob Heart.\u00a02015;10:63\u201369 e1.","DOI":"10.1016\/j.gheart.2014.10.001"},{"key":"1592_CR77","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12939-017-0700-1","volume":"16","author":"H Barker","year":"2017","unstructured":"Barker H, Oetzel JG, Scott N, Morley M, Carr PEA, Oetzel KB. Enablers and barriers to secondary prophylaxis for rheumatic fever among Maori aged 14\u201321 in New Zealand: a framework method study. Int J Equity Health. 2017;16:201.","journal-title":"Int J Equity Health"},{"key":"1592_CR78","first-page":"54","volume":"54","author":"R Kumar","year":"2002","unstructured":"Kumar R, Raizada A, Aggarwal AK, Ganguly NK. A community-based rheumatic fever\/rheumatic heart disease cohort: twelve-year experience. Indian Heart J. 2002;54:54\u20138.","journal-title":"Indian Heart J"},{"key":"1592_CR79","doi-asserted-by":"publisher","first-page":"514","DOI":"10.5694\/j.1326-5377.2006.tb00347.x","volume":"184","author":"Z Harrington","year":"2006","unstructured":"Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J. Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust. 2006;184:514\u20137.","journal-title":"Med J Aust"},{"key":"1592_CR80","unstructured":"World Health Organization. Report of the Commission on Macroeconomics and health. 2002."},{"key":"1592_CR81","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5830\/CVJA-2015-090","volume":"27","author":"D Watkins","year":"2016","unstructured":"Watkins D, Zuhlke L, Engel M, et al. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqu\u00e9: cardiovascular topics. Cardiovasc J Afr. 2016;27:184\u20137.","journal-title":"Cardiovasc J Afr"},{"key":"1592_CR82","unstructured":"Oyebamiji O. The household economic impact of rheumatic heart disease (RHD) in South Africa. University of Cape Town, 2018."},{"key":"1592_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-11314-6","volume":"21","author":"AG Hellebo","year":"2021","unstructured":"Hellebo AG, Zuhlke LJ, Watkins DA, Alaba O. Health system costs of rheumatic heart disease care in South Africa. BMC Public Health. 2021;21:1\u201311.","journal-title":"BMC Public Health"},{"key":"1592_CR84","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ihj.2021.01.022","volume":"73","author":"AO Mocumbi","year":"2021","unstructured":"Mocumbi AO. Out-of-pocket costs in rheumatic heart disease care: a major barrier to equity in cardiovascular health. Indian Heart J. 2021;73:141.","journal-title":"Indian Heart J"},{"key":"1592_CR85","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ihj.2020.11.151","volume":"73","author":"B Arvind","year":"2021","unstructured":"Arvind B, Saxena A, Kazi DS, Bolger AF. Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: a registry-based data from a tertiary care center in Northern India. Indian Heart J. 2021;73:169\u201373.","journal-title":"Indian Heart J"},{"key":"1592_CR86","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/ijerph17041347","volume":"17","author":"E Haynes","year":"2020","unstructured":"Haynes E, Mitchell A, Enkel S, Wyber R, Bessarab D. Voices behind the statistics: a systematic literature review of the lived experience of rheumatic heart disease. Int J Environ Res Public Health. 2020;17:1347.","journal-title":"Int J Environ Res Public Health"},{"key":"1592_CR87","doi-asserted-by":"publisher","first-page":"112","DOI":"10.21608\/jhiph.2013.19997","volume":"43","author":"D Monib","year":"2013","unstructured":"Monib D, Wahdan I, Hasab A, Zaher S. Health related quality of life of rheumatic heart disease patients in Alexandria: an intervention approach. Journal of High Institute of Public Health. 2013;43:112\u201320.","journal-title":"Journal of High Institute of Public Health"},{"key":"1592_CR88","first-page":"370","volume":"68","author":"A Riaz","year":"2018","unstructured":"Riaz A, Hanif MI, Khan IH, Hanif A, Mughal S, Anwer A. Quality of life in patients with rheumatic heart disease. J Pakistan Med Assoc. 2018;68:370\u20135.","journal-title":"J Pakistan Med Assoc"},{"key":"1592_CR89","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jpeds.2016.04.087","volume":"175","author":"T Bradley-Hewitt","year":"2016","unstructured":"Bradley-Hewitt T, Dantin A, Ploutz M, et al. The impact of echocardiographic screening for rheumatic heart disease on patient quality of life. J Pediatr. 2016;175:123\u20139.","journal-title":"J Pediatr"},{"key":"1592_CR90","doi-asserted-by":"crossref","unstructured":"Z\u00fchlke L, Perkins S, Cembi S. Rheumatic heart disease patient event: Cape Town hosts 4th annual listen to my heart rheumatic heart disease for patients at the South African heart association meeting in 2017. Oxford University Press, 2018.","DOI":"10.1093\/eurheartj\/ehy199"},{"key":"1592_CR91","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/trstmh\/trz014","volume":"113","author":"CK Macleod","year":"2019","unstructured":"Macleod CK, Bright P, Steer AC, Kim J, Mabey D, Parks T. Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease. Trans R Soc Trop Med Hyg. 2019;113:287\u201390.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1592_CR92","unstructured":"World Health Organization. 71st World Health Assembly adopts resolution calling for greater action on rheumatic heart disease. Seventy-First World Health Assembly World Health Organization, Geneva, Switzerland 2018. https:\/\/www.who.int\/about\/governance\/world-health-assembly\/seventy-first."},{"key":"1592_CR93","unstructured":"World Health Organization. Rheumatic fever and rheumatic heart disease. Report by the Director General. Seventy-First World Health Assembly World Health Organization, Geneva, Switzerland 2018. https:\/\/apps.who.int\/iris\/handle\/10665\/276479."},{"key":"1592_CR94","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1161\/CIR.0000000000000922","volume":"142","author":"A Beaton","year":"2020","unstructured":"Beaton A, Kamalembo FB, Dale J, et al. The American Heart Association\u2019s call to action for reducing the global burden of rheumatic heart disease: a policy statement from the American Heart Association. Circulation. 2020;142:e358\u201368.","journal-title":"Circulation"},{"key":"1592_CR95","doi-asserted-by":"crossref","unstructured":"Mayosi BM, Gamra H, Dangou JM, Kasonde J. 2nd All-Africa Workshop on Rheumatic Fever and Rheumatic Heart Disease participants. Rheumatic heart disease in Africa: the Mosi-o-Tunya call to action. Lancet Glob Health. 2014;2:e438\u20139.","DOI":"10.1016\/S2214-109X(14)70234-7"},{"key":"1592_CR96","doi-asserted-by":"crossref","unstructured":"Dale\u00a0JB, Walker MJ.\u00a0Update on group A streptococcal vaccine development. Curr Opin Infect Dis. 2020;33:244\u2013250.","DOI":"10.1097\/QCO.0000000000000644"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01592-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-021-01592-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01592-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T06:22:36Z","timestamp":1675750956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-021-01592-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1592"],"URL":"https:\/\/doi.org\/10.1007\/s11886-021-01592-2","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"assertion":[{"value":"26 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This study complies with ethical standards. As no primary patient data was collected, Institutional Review Board approval and informed consent were not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}],"article-number":"160"}}